Lysergic acid
Template:Short description Template:Distinguish Template:Chembox
Lysergic acid, also known as Template:Sc-lysergic acid and (+)-lysergic acid, is a precursor for a wide range of ergoline alkaloids that are produced by the ergot fungus and found in the seeds of Argyreia nervosa (Hawaiian baby woodrose), and Ipomoea species (morning glories, ololiuhqui, tlitliltzin).
Amides of lysergic acid, lysergamides, are widely used as pharmaceuticals and as psychedelic drugs, e.g. lysergic acid diethylamide (LSD). Lysergic acid is listed as a Table I precursor under the United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.<ref>Template:Cite web</ref>
The name "lysergic acid" comes from the fact that it is a carboxylic acid, and it was first made by hydrolysis of various ergot alkaloids.<ref name=Schiff>Template:Cite journal</ref>
Pharmacology
Lysergic acid failed to produce LSD-like electroencephalogram (EEG) changes in rabbits.<ref name="SiddikBarnesDring1979">Template:Cite journal</ref>
Chemistry
Synthesis
Laboratory
Lysergic acid is generally produced by hydrolysis<ref>Template:Cite journal</ref> of natural lysergamides, but can also be synthesized in the laboratory by a complex total synthesis, for example by Robert Burns Woodward's team in 1956.<ref>Template:Cite journal</ref> An enantioselective total synthesis based on a palladium-catalyzed domino cyclization reaction has been described in 2011 by Fujii and Ohno.<ref name=ohno1>Template:Cite journal</ref> Lysergic acid monohydrate crystallizes in very thin hexagonal leaflets when recrystallized from water. Lysergic acid monohydrate, when dried (140 °C at Template:Convert) forms anhydrous lysergic acid.
Biosynthesis
The biosynthetic route is based on the alkylation of the amino acid tryptophan with dimethylallyl diphosphate (isoprene derived from 3R-mevalonic acid) giving 4-dimethylallyl-Template:Sc-tryptophan which is N-methylated with [[S-adenosyl-L-methionine|S-adenosyl-Template:Sc-methionine]]. Oxidative ring closure followed by decarboxylation, reduction, cyclization, oxidation, and allylic isomerization yields Template:Sc-(+)-lysergic acid.<ref name=Schiff /> The biosynthetic pathway has been reconsituted in transgenic baker's yeast.<ref name=Wong2022>Template:Cite journal</ref>
Isomers
Lysergic acid is a chiral compound with two stereocenters. The isomer with inverted configuration at carbon atom 8 close to the carboxyl group is called isolysergic acid. Inversion at carbon 5 close to the nitrogen atom leads to Template:Sc-lysergic acid and Template:Sc-isolysergic acid, respectively.
Society and culture
Legal status
In the United States, Lysergic acid and Lysergic acid amide are Schedule III substances.<ref>Template:Cite web</ref>